Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
X0405037	注射用雷替曲塞	raltitrexed	Lyophilized	Chemical Drugs(3.1)	New Drug Application	2004-09-05	成都耐切尔生物技术有限公司	Chengdu Nether Biotechnology Co Ltd	Certificate Issued	2006-09-06	view
X0405036	雷替曲塞	raltitrexed	Active ingredient	Chemical Drugs(3.1)	New Drug Application	2004-09-05	成都耐切尔生物技术有限公司	Chengdu Nether Biotechnology Co Ltd	Certificate Issued	2006-09-06	view
CXHL0500961	9-硝基喜树碱	rubitecan	Active ingredient	Chemical Drugs(1.1)	New Drug Application	2005-07-02	成都耐切尔生物技术有限公司	Chengdu Nether Biotechnology Co Ltd	Certificate Issued	2008-04-06	view
CXHL0500963	9-硝基喜树碱胶囊	rubitecan	Capsule	Chemical Drugs(1.1)	New Drug Application	2005-07-02	成都耐切尔生物技术有限公司	Chengdu Nether Biotechnology Co Ltd	Certificate Issued	2008-04-06	view
CXHL0500962	9-硝基喜树碱片	rubitecan	Tablet	Chemical Drugs(1.1)	New Drug Application	2005-07-02	成都耐切尔生物技术有限公司	Chengdu Nether Biotechnology Co Ltd	Certificate Issued	2008-04-06	view